𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer

✍ Scribed by Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; Stearns, V.; Doane, A. S.; Danso, M.; Moynahan, M. E.; Momen, L. F.; Gonzalez, J. M.; Akhtar, A.; Giri, D. D.; Patil, S.; Feigin, K. N.; Hudis, C. A.; Traina, T. A.

Book ID
121694739
Publisher
American Association for Cancer Research
Year
2013
Tongue
English
Weight
312 KB
Volume
19
Category
Article
ISSN
1078-0432

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase 2 randomized trial of primary endo
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/